BioRestorative Therapies Inc expected to post a loss of 12 cents a share - Earnings Preview

Biorestorative Therapies

04/09/2026 12:04

BioRestorative Therapies Inc BRTX.OQ BRTX.O is expected to  show a rise in quarterly revenue when it reports  results on September 7 (estimated) for the period ending June 30 2026
The Melville New York-based  company is expected to report a 10.6% increase in revenue to $335 thousand from $303 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for BioRestorative Therapies Inc is for a loss of 12 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for BioRestorative Therapies Inc is $8.00, about 5,467.2% above its last closing price of $0.14
This summary was machine generated September 4 at 11:04 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)